CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had revenue of $7.79M in the quarter ending September 30, 2024, a decrease of -11.82%. This brings the company's revenue in the last twelve months to $22.06M, down -47.82% year-over-year. In the year 2023, CASI Pharmaceuticals had annual revenue of $33.88M, down -21.41%.

• Revenue (ttm): $22.06M
• Revenue Growth: -47.82%
• P/S Ratio: 3.31
• Revenue / Employee: $125,313
• Employees: 176
• Market Cap: 79.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	33.88M	-9.23M	-21.41%
Dec 31, 2022	43.11M	12.94M	42.89%
Dec 31, 2021	30.17M	15.03M	99.25%
Dec 31, 2020	15.14M	11.01M	266.52%
Dec 31, 2019	4.13M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.